PitchBook: US venture funding hit $412.7B in H1 2026, up 30% on all of 2025, with AI startup funding accounting for 86%, or $355.9B; Q2 saw seven $1B+ rounds
Context & Ripple Effects
PitchBook’s related coverage shows a sustained recovery in US startup financing: funding strengthened in 2024 and reached $162.8B in H1 2025, with AI increasingly driving the rebound.
The defining change is concentration. AI’s share of US VC rose from nearly half of Q2 2024 funding to about two-thirds in H1 2025 and now accounts for 86% of the H1 2026 total, alongside a revival in growth- and late-stage fundraising.
First-order effects
- AI startups, especially those able to raise at late-stage scale, gain a far larger pool of available capital; the seven $1B-plus Q2 rounds underscore that the financing surge is concentrated in a small number of companies.
- Non-AI startups are competing for the remaining slice of venture funding, even as aggregate US VC investment reaches a new level.
Second-order effects
- VC firms and growth investors face pressure to secure exposure to AI leaders, likely reinforcing larger round sizes and directing fund-raising capacity toward later-stage AI investments.
- The widening funding gap can make it harder for startups outside the AI category to finance growth on comparable terms, increasing the relative importance of capital efficiency and differentiated investor appeal.
Third-order effects
- If this concentration persists, US venture markets could become more dependent on outcomes from a narrow set of heavily financed AI companies rather than a broadly distributed startup recovery.
- The pattern points to a more barbelled venture market: a handful of AI companies financed at very large scale, alongside a larger population of companies operating with scarcer institutional capital.
The trend: The venture-cycle recovery is becoming an AI-led capital-concentration cycle, with late-stage funding and mega-rounds carrying an outsized share of market activity.